Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Abstract Text:

R A Gams,J T Carpenter,

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Publishing Authors By Initials

RA Gams,JT Carpenter,

For similar organic chemicals: triazenes research abstracts see: organic chemicals: triazenes research

PUBMED ID PMID:

MEDLINE DATE: 1974 Sep-Oct

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 58

Page Numbers: 753-4

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: 02

YEAR: 2008

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Keywords Mesh Terms:

KEYWORDS: Triazenes

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Information

Substance Name: Doxorubicin

Registry Number: 23214-92-8

Grant and Affiliation Information for Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Central nervous system complications after combination treatment with adriamycin NSC-123127 and 5-3,3-dimethyl-1-triazenoimidazole-4-carboxamide NSC-45388 Related Publications

• "For mothers only": mothers' convalescent homes and modernizing maternal ideology in 1950s West Germany.
• 2007 hospital supply chain technology survey. Supply chain IT gap narrows.
• Aquatic eutrophication promotes pathogenic infection in amphibians.
• Asthma and infectious respiratory disease in children - correlation to residence near hazardous waste sites.
• Calcium and vitamin D: what is known about the effects on growing bone.
• Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.
• CellProfiler: free, versatile software for automated biological image analysis.
• Challenges faced by health workers in implementing the prevention of mother-to-child HIV transmission (PMTCT) programme in Uganda.
• Deconstructing and reconstructing illness syndromes associated with psychosis.
• Effects of polycyclic aromatic hydrocarbon-containing oil mixtures on generation of reactive oxygen species and cell viability in MCF-7 breast cancer cells.
• Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
• Employment after spinal cord injury: the impact of government policies in Canada.
• ErbB receptors: new insights on mechanisms and biology.
• ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains.
• Estrus and pregnancy rates following synchronization with chronolone intravaginal sponge or norgestomet ear implant in cycling ewes.
• Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
• Increased rate of hospitalization for diabetes and residential proximity of hazardous waste sites.
• Optimizing diagnosis from the medical liver biopsy.
• Purification of triglycerides with an alumina column.
• Ratbite fevers.
• Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression.
• Second Canadian EM Residents' Workshop: review.
• Stress, optimism, and social support: impact on immune responses in breast cancer.
• Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults.
• Temperament and response to the Trier Social Stress Test.
• The impetus for family-centred early childhood intervention.
• The prevalence of seat belt use in Kingston, Jamaica: a follow-up observational study five years after the introduction of legislation.
• The role of metals in the etiology of Alzheimer's disease.
• Weight gain as an impediment to cigarette smoking cessation: a lingering problem in need of solutions.
• Why it is essential to go on the record.